{"denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Up to 15.9 months","title":"Phase 1 and Phase 2a: Number of Participants With Neutralizing Antibodies (NAb) Against Study Drug","type":"SECONDARY"}